Therapy of intestinal protozoa

Trends in Parasitology

Volumn 19, Issue 11, 2003, Pages 523-526

  Petri Jr , William A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; DILOXANIDE FUROATE; FURAZOLIDONE; GLUCURONIDE TIZOXANIDE; MEPACRINE; METRONIDAZOLE; NITAZOXANIDE; NITROIMIDAZOLE; ORNIDAZOLE; PAROMOMYCIN; SECNIDAZOLE; TINIDAZOLE; TIZOXANIDE; UNCLASSIFIED DRUG;

AMEBIASIS; BRAIN DISEASE; COCCIDIOSIS; CONVULSION; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; CYCLOSPORA CAYETANENSIS; DRUG SENSITIVITY; ENTAMOEBA HISTOLYTICA; GIARDIA LAMBLIA; GIARDIASIS; HEADACHE; HUMAN; INTESTINE PARASITE; ISOSPORA BELLI; MICROSPORIDA; MUSCLE CRAMP; NAUSEA; NONHUMAN; REVIEW; STANDARD; VOMITING; XEROSTOMIA;

CRYPTOSPORIDIUM PARVUM; CYCLOSPORA CAYETANENSIS; ENCEPHALITOZOON INTESTINALIS; ENTAMOEBA HISTOLYTICA; FUNGI; GIARDIA INTESTINALIS; ISOSPORA BELLI; MICROSPORIDIA; PROTOZOA;

EID: 0142196033     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2003.09.003     Document Type: Review

References (26)

1. Diamond L.S., Clark C.G. A redescription of Entamoeba histolytica Shaudin 1903 (amended Walker 1911) separating it from Entamoeba dispar (Brumpt 1925). J. Eukaryot. Microbiol. 40:1993;340-344.
2. Ali, I.K.M. et al. High prevalence of Entamoeba moshkovskii infections in children in Bangladesh. Emerg. Infect. Dis. (in press).
3. Haque R., et al. Diagnosis of amebic liver abscess and intestinal infection with the TechLab Entamoeba histolytica II antigen detection and antibody tests. J. Clin. Microbiol. 38:2000;3235-3239.
4. Haque R., et al. Innate and acquired resistance to amebiasis in Bangladeshi children. J. Infect. Dis. 186:2002;547-552.
5. Blessmann J., et al. Epidemiology of amebiasis in a region of high incidence of amebic liver abscess in central Vietnam. Am. J. Trop. Med. Hyg. 66:2002;578-583.
6. WHO/PAHO/UNESCO report of a consultation of experts on amoebiasis. Weekly Epidemiological Report of the WHO. 72:1997;97-99.
7. Powell S.J., et al. Metronidazole in amoebic dysentery and amoebic liver abscess. Lancet. i:1967;1329-1331.
8. Blessmann J., Tannich E. Treatment of asymptomatic intestinal Entamoeba histolytica infection. N. Engl. J. Med. 347:2002;1384.
9. McAuley J.B., et al. Diloxanide furoate for treating asymptomatic Entamoeba histolytica cyst passers: 14 years experience in the United States. Clin. Infect. Dis. 15:1992;464-468.
10. McAuley J.B., Juranek D.D. Paromomycin in the treatment of mild to moderate intestinal amebiasis. Clin. Infect. Dis. 15:1992;551-552.
11. Stockis A., et al. Nitazoxanide pharmacokinetics and tolerability in man after single ascending doses. Int. J. Clin. Pharmacol. Ther. 40:2002;213-220.
12. Broekhuysen J., et al. Nitazoxanide: pharmacokinetics and metabolism in man. Int. J. Clin. Pharmacol. Ther. 38:2000;387-394.
13. Rossignol J.-F., et al. Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide. J. Infect. Dis. 184:2001;381-384.
14. Adagu I.S., et al. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. J. Antimicrob. Chemother. 49:2002;103-111.
15. Van Sonnenberg E., et al. Intrahepatic amebic abscesses: indications for and results of percutaneous catheter drainage. Radiology. 156:1985;631-635.
16. Shamsuzzaman S.M., et al. Socioeconomic status, clinical features, laboratory and parasitological findings of hepatic amebiasis patients - a hospital based prospective study in Bangladesh. Southeast Asian J. Trop. Med. Public Health. 31:2000;399-404.
17. Hewitt R.G., et al. Paromomycin in cryptosporidiosis. Reply. Clin. Infect. Dis. 32:2001;1517.
18. Rossignol J.F.A., et al. Treatment of diarrhea caused by Cryptosporidium parvum: A prospective randomized double blind placebo-controlled study of nitazoxanide. J. Infect. Dis. 184:2001;103-106.
19. Anon. Nitazoxanide - a new anti-protozoal agent. Med. Lett. Drugs Ther. 45:2003;29-31.
20. Amadi B., et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet. 360:2002;1375-1380.
21. Hoge C.W., et al. Placebo-controlled trial of co-trimoxazole for cyclospora infections among travelers and foreign residents in Nepal. Lancet. 345:1995;691-693.
22. Pape J.W., et al. Cyclospora infection in adults infected with HIV. Clinical manifestations, treatment and prophylaxis. Ann. Intern. Med. 121:1994;654-657.
23. Dieterich D.T., et al. Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS. J. Infect. Dis. 169:1994;178-183.
24. Nash T.E., et al. Treatment of patients with refractory giardiasis. Clin. Infect. Dis. 33:2001;22-28.
25. Abboud P., et al. Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome. Clin. Infect. Dis. 32:2001;1792-1794.
26. Petri W.A. Jr., et al. Estimating the impact of amebiasis on health. Parasitol. Today. 16:2000;320-321.